Nazario Foschi

ORCID: 0000-0003-0464-0788
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Bladder and Urothelial Cancer Treatments
  • Ureteral procedures and complications
  • Prostate Cancer Diagnosis and Treatment
  • Urinary and Genital Oncology Studies
  • Urological Disorders and Treatments
  • Urinary Bladder and Prostate Research
  • Renal cell carcinoma treatment
  • Pediatric Urology and Nephrology Studies
  • Kidney Stones and Urolithiasis Treatments
  • Pelvic floor disorders treatments
  • Colorectal Cancer Surgical Treatments
  • Urinary Tract Infections Management
  • Cardiac, Anesthesia and Surgical Outcomes
  • Renal and Vascular Pathologies
  • Cancer Immunotherapy and Biomarkers
  • Ovarian cancer diagnosis and treatment
  • Cervical Cancer and HPV Research
  • Abdominal Surgery and Complications
  • Endometrial and Cervical Cancer Treatments
  • Prostate Cancer Treatment and Research
  • Genital Health and Disease
  • Renal and related cancers
  • Urologic and reproductive health conditions
  • Appendicitis Diagnosis and Management
  • Inflammatory Biomarkers in Disease Prognosis

Agostino Gemelli University Polyclinic
2015-2025

Università Cattolica del Sacro Cuore
2009-2025

Istituti di Ricovero e Cura a Carattere Scientifico
2020-2025

University of the Sacred Heart
2016-2023

University of Chieti-Pescara
2022

Pontifícia Universidade Católica de São Paulo
2016

University of Milan
1994

Ospedali Riuniti di Ancona
1990

Istituto di Sessuologia Clinica
1990

Background and Objectives: To assess the potential prognostic role of systemic immune-inflammation index (SII) in predicting oncological outcomes a cohort patients treated with radical cystectomy (RC). Materials Methods: From 2016 to 2022, retrospective monocentric study enrolled 193 who were divided into two groups based on their SII levels using optimal cutoff determined by Youden index. The was obtained from preoperative blood test approximately one month before RC. Univariable...

10.3390/medicina59122063 article EN cc-by Medicina 2023-11-22

Inflammation is widely acknowledged as a significant characteristic of cancer, playing substantial function in both the initiation and advancement cancers. In this research, we planned to compare pan-immune inflammation markers other well-known (systemic immune index neutrophil lymphocyte ratio) predict prognosis individuals treated with radical cystectomy for bladder cancer. Methods: retrospective analysis, focused on preoperative PIV, systemic (SII), neutrophil–lymphocyte ratio (NLR) 193...

10.3390/cancers16030651 article EN Cancers 2024-02-03

Hyperthermic intraperitoneal chemotherapy (HIPEC) is a current treatment option for peritoneal carcinosis (PC) after cytoreductive surgery (CRS). Genital skin alterations are rare complications reported variously HIPEC using Mitomycin-C.

10.1016/j.ijscr.2024.110797 article EN International Journal of Surgery Case Reports 2025-01-01

The study was conducted from December 2011 to 2012 on 95 patients between the ages of 20 and 65 years: 44 which had been undergoing dialysis for over a year 51 whom undergone kidney transplants more than 6 months before. Comorbidities were carefully recorded, erectile function evaluated with IIEF5 questionnaire serum levels total testosterone / free prolactin tested at early morning (7 AM). To assess relationship dysfunction (ED) clinical laboratory tests, Student's t-test statistical...

10.4081/aiua.2015.4.299 article EN cc-by-nc Archivio Italiano di Urologia e Andrologia 2016-01-14

Inflammation is widely acknowledged as a significant characteristic of cancer, playing substantial function in both the initiation and advancement cancers. In this research, we planned to investigate comparison among pan-immune inflammation markers other well-known (systemic immune index neutrophil lymphocyte ratio) predict prognosis individuals treated with radical cystectomy for bladder cancer. Methods: retrospective analysis, focused on preoperative PIV, systemic (SII),...

10.20944/preprints202401.0298.v1 preprint EN 2024-01-04

Indocyanine green (ICG), a well-known molecule employed in medicine for over five decades, has emerged as versatile dye widely embraced across various surgical disciplines. In gynecologic oncology, its prevalent use revolves around the detection of sentinel lymph nodes. However, true potential ICG extends beyond this singular application, owing to pragmatic utility, cost-effectiveness, and safety profile. Furthermore, been introduced theranostic landscape, marking significant juncture...

10.1097/js9.0000000000001318 article EN cc-by-nc-nd International Journal of Surgery 2024-03-15

<title>Abstract</title> Minimally invasive surgery like robotic is known to yield better outcomes in terms of blood loss, transfusion, and length stay, robot-assisted radical prostatectomy provides a clear example compared open surgery. It still constrained by issues related platform availability cost-effectiveness. Introducing new platforms, such as the HUGO™ Robot-Assisted Surgery (RAS) System, could lead longer operating times caused surgeon's learning curve, system configuration,...

10.21203/rs.3.rs-5782260/v1 preprint EN cc-by Research Square (Research Square) 2025-01-13

Abstract Purpose To propose an obstetric management model for patients with congenital bladder exstrophy (BE) and multiple previous surgeries, recognizing the unique anatomical variations of each patient emphasizing importance personalized treatment approaches. Methods We present delivery a 32-year-old pregnant woman BE, focusing on antenatal assessment, accurate planning key surgical steps during elective caesarean section. Additionally, we conduct comprehensive review current literature to...

10.1007/s00404-025-07937-4 article EN cc-by Archives of Gynecology and Obstetrics 2025-01-31

This analysis aimed to evaluate the clinical relevance of presurgical systemic inflammation response index (SIRI) in individuals undergoing radical cystectomy (RC). In this retrospective study, 228 were categorized into 2 cohorts depending on their SIRI levels using best cut-off determined by Youden Index. The association between and lymph node metastasis (N), advanced pT stage (pT3/pT4), loco-regional extended state analyzed at time surgery. Multivariate Cox regression was performed impact...

10.1016/j.urolonc.2025.01.007 article EN cc-by Urologic Oncology Seminars and Original Investigations 2025-02-01

Background/Objectives: Bladder cancer is a multifactorial disease, ranking as the 10th most common globally and fourth in men ninth women Western world. This bibliometric analysis aims to identify evaluate scientific literature addressing new biomarkers for bladder diagnosis, well prolific organizations, authors, journals, countries, keywords within this research domain.Methods: An electronic search was conducted using Elsevier's Scopus database. From total of 940 retrieved papers (published...

10.4081/aiua.2025.13396 article EN cc-by-nc Archivio Italiano di Urologia e Andrologia 2025-02-11

Abstract Background Hugo RAS is a novel robotic platform gaining global adoption. Most reported outcomes come from centers with prior Da Vinci experience, limited data robotic-naïve settings or comparisons based on expertise. Objective To compare of robot-assisted radical prostatectomy (RARP) performed by Vinci-experienced (DVE) versus non-Da (NDVE) surgeons. Design, Setting, and Participants: Prospective patients undergoing Hugo-RARP (July 2022–November 2024) were analyzed. Patients grouped...

10.1007/s00345-025-05608-2 article EN cc-by World Journal of Urology 2025-04-20

Abstract We compared the efficacy and safety of pergolide bromocriptine in 57 patients with Parkinson's disease (PD) a declining response to levodopa therapy single‐blind, crossover study. Patients were placed randomly on sequence bromocriptine‐pergolide (12 + 12 weeks) or vice versa. Regular evaluations using New York University Disease Scale performed by clinician blinded treatment assignment. Patients' clinicians' impressions also recorded. The average daily dose was 2.3 ± 0.8 mg, that...

10.1002/mds.870090409 article EN Movement Disorders 1994-01-01

Background/Aim: Recent evidence suggests potential synergistic antitumor effects of the combination programmed death-1 (PD-1)/programmed death-ligand 1 (PD-L1) immune checkpoint inhibitors with oral hypoglycemic agent metformin. The aim this study was to investigate safety and activity metformin combined nivolumab in diabetic cancer patients. Patients Methods: advanced melanoma, renal cell carcinoma or lung receiving concurrent diabetes treated were retrospectively collected. primary...

10.21873/anticanres.15620 article EN Anticancer Research 2022-02-26
Coming Soon ...